DAIC

MARCH 14, 2025

Some of the late-breaking topics that will be covered include transcatheter aortic valve replacement (TAVR), peripheral artery disease (PAD), and pulmonary embolism (PE): Impact of Age on Procedural Timing for Asymptomatic Severe Aortic Stenosis: Results from the Early TAVR Trial The PERFORMANCE II Trial: A Prospective Multicenter Single Arm Investigation (..)

TAVR 52

TAVR Aortic valve Peripheral Arterial Disease Embolism 52

Frontiers in Cardiovascular Medicine

AUGUST 7, 2024

However, with the compelling evidence on the safety and efficacy of transcatheter aortic valve replacement (TAVR), it has become the gold standard treatment option for many patients with symptomatic severe AS. Therefore, alternative TAVR approaches have gained increasing utility in cases where transfemoral access is unfavorable.

Aortic valve 98

Aortic valve Aortic TAVR Peripheral Arterial Disease 98

Coronary Artery Disease Journal

MAY 13, 2024

Objective To investigate the impact of prior coronary artery bypass grafting (CABG) and coronary lesion complexity on transcatheter aortic valve replacement (TAVR) outcomes for aortic stenosis. The CABG SYNTAX score did not influence the prognosis after TAVR. The median CABG SYNTAX score was 16 (interquartile range: 9.0–23),

Coronary Artery Bypass Graft 40

Coronary Artery Bypass Graft Aortic valve Aortic Stenosis 40

DAIC

MAY 1, 2024

Featuring numerous abstracts with fresh insights into health disparities, efficacy data for TAVR, and innovative strategies for PAD, we eagerly anticipate the convergence of professionals from diverse specialties. About 276,000 patients have undergone a TAVR procedure in the United States. PAD contributes to 400 amputations each day.

Interventional Cardiology 105

Interventional Cardiology Aortic valve TAVR Peripheral Arterial Disease 105

Frontiers in Cardiovascular Medicine

APRIL 24, 2024

However, HGPS patient-device size mismatch, pervasive peripheral arterial disease, skin and bone abnormalities, and lifelong failure to thrive present unique challenges to intervention. Two cases received TAVR and 2 received AAC post-summit.

Stenosis 52

Stenosis Aortic Peripheral Arterial Disease TAVR 52